Comprehensive Erdafitinib Support Protocol

XIX

XIX

Evil Misogynist
Joined
Sep 4, 2023
Posts
655
Reputation
658

DISCLAIMER:

This is not medical advice, and the only purpose this serves is a sarcastic interpretation of someone trying to help mitigate the side effects of people already on Erdafitinib.

Much safer alternatives to Erdafitinib exist e.g. Infigratinib, and no side effect can be completely mitigated.
ERDAFITINIB CAN LEAD TO BLINDNESS, KYPHOSIS, SCOLIOSIS AND SO MUCH MORE.


Erdafitinib Support Protocol

Erdafitinib works by blocking FGFR receptors 1 through 4 throughout the body. Because these receptors also regulate normal processes unrelated to cancer signaling — phosphate balance, methylation, cAMP production, retinal fluid transport — inhibiting them produces a predictable set of off-target effects. countering it early is the point of this protocol.



1. Hyperphosphatemia

FGFR signaling normally activates FGF23, a bone hormone that tells the kidneys to excrete excess phosphate. Blocking FGFR removes that signal, so phosphate climbs — quietly, with no short-term symptoms. Left unchecked over months, it binds calcium and deposits in blood vessels and organs (vascular calcification), which is largely irreversible and raises both cardiovascular risk and the rate of kidney decline.

Target: serum phosphate below 5.5 mg/dL, checked every 3–4 weeks early in treatment.

Counter — Sevelamer, 800 mg with every meal. A non-absorbed gut binder: it captures dietary phosphate before it crosses into the bloodstream and carries it out in stool, so it doesn't interact with erdafitinib itself. It only works with food — useless taken on an empty stomach. Separate it from fat-soluble vitamins by at least 2 hours, since it reduces their absorption too.

2. Methylation Burden

Methylation moves a methyl group from SAM-e to other molecules and runs constantly — detox, gene expression, neurotransmitter synthesis, drug metabolism all draw on it. Erdafitinib is partly cleared through this same pathway, so it consumes SAM-e on top of everything else. Over time, demand outpaces what diet replenishes, the cycle backs up, and homocysteine rises — itself a risk factor for cardiovascular disease, clotting, and cognitive decline, and one that compounds the cardiovascular strain from elevated phosphate. Creatine synthesis alone accounts for a large share of the body's methyl-group demand.

Counter — Methyl Support
  • Creatine monohydrate, 5 g/day — supplementing bypasses the body's own creatine synthesis (normally ~40% of daily methyl demand), freeing up SAM-e elsewhere. No loading phase needed.​
  • Betaine (TMG), 3 g/day, split into two doses — donates methyl groups directly and converts homocysteine back to methionine through a pathway that doesn't depend on B12 or folate, actively clearing the buildup.​

3. Suppressed cAMP Signaling

cAMP is an intracellular messenger that governs energy metabolism, inflammation, cell survival, and hormone response. FGFR signaling normally feeds into cAMP production, so blocking it cuts that input. The downstream effects — lower mitochondrial output, impaired fat metabolism, reduced stress tolerance, blunted immune surveillance — show up mainly as a fatigue that builds gradually and doesn't resolve with sleep.

Counter — cAMP Support
  • Abaloparatide, 80 mcg (preferred where affordable) — a PTH-related protein analogue that activates PTH1R, a receptor coupled to adenylyl cyclase (the enzyme that produces cAMP), restoring output through a pathway independent of the blocked FGFR signal.​
  • Forskolin, 1 g/day (cheaper alternative) — activates adenylyl cyclase directly, without needing a receptor, raising cAMP broadly.​

4. Ocular Effects

FGFR receptors in the retinal pigment epithelium, choroid, and cornea help regulate fluid transport. Blocking them disrupts subretinal fluid balance, which can cause central serous retinopathy (CSR) — fluid accumulating under the retina, distorting central vision and reducing contrast. It develops slowly enough that many people don't notice until it's already significant. The same blockade disrupts the tear film, causing dry eye.

Counter — Eye Protection
  • Dorzolamide eye drops, started at 2–3 months in or at the first visual symptom — a topical carbonic anhydrase inhibitor that reduces subretinal fluid production, addressing CSR directly, with minimal systemic exposure. Use preservative-free formulations.​
  • Lubricating drops as needed for dryness; switch to preservative-free if used more than 4x/day.​

5. Dehydration and Kidney Load

Erdafitinib clears through the liver, then the kidneys. Inadequate hydration raises drug-metabolite concentration with each filtration cycle, compounding the kidney stress already caused by elevated phosphate — and it further concentrates circulating phosphate, undermining the sevelamer, while also worsening dry eye and fatigue. It's the most overlooked piece of this protocol because it has no dramatic acute symptom to flag it.

Counter — Hydration Protocol
  • 3 L water/day — 500 mL first thing in the morning, the rest spread through the day rather than taken all at once, to avoid diluting sodium.​
  • Electrolytes daily — a sugar-free sodium/potassium/magnesium supplement, dissolved in at least 1 L of the daily water.​
  • Saffron extract (crocetin), 30 mg/day — supports renal microcirculation and reduces inflammatory signaling in the kidney.​


TL;DR: Protocol

ED, from day one:
  • Creatine monohydrate — 5 g​
  • Betaine (TMG) — 3 g, split morning/evening​
  • Abaloparatide 80 mcg or forskolin 1 g​
  • Saffron extract (crocetin) — 30 mg​
  • Sevelamer — 800 mg with every meal​
  • Electrolytes + 3 L water, spread through the day​

Starting at 2–3 months, or at first visual symptom:
  • Dorzolamide eye drops (preservative-free preferred)​
  • Lubricating drops (preservative-free if used more than 4x/day)​

Monitoring / Bloodwork:
  • Serum phosphate — target below 5.5 mg/dL​
  • Kidney function markers — every 4–6 weeks​
  • Vision — central clarity/contrast​
  • Homocysteine — every 8 weeks​

Every item on this list has a specific job targeting a specific side effect, so take them all.

@Volpa #volpamogs
 
  • +1
Reactions: 2s2f, Klassek, Niebvll and 2 others
Bumped
 
  • +1
  • Love it
Reactions: 2s2f, Klassek and XIX
bump
@Niebvll @buccalfatremoval @Anakin. @Klassek @smartfoiddestroyer2 @2s2f @Stalker @LowTierBateman @ZyzzReincarnate @808AmnesiaLuver @occipital @kantho
 
  • +1
Reactions: 2s2f and Klassek
bump
@Niebvll @buccalfatremoval @Anakin. @Klassek @smartfoiddestroyer2 @2s2f @Stalker @LowTierBateman @ZyzzReincarnate @808AmnesiaLuver @occipital @kantho
Only first 5 person will get a notif bhai
 
  • JFL
  • +1
Reactions: 2s2f and XIX
Water but yeah cool
 
  • +1
  • JFL
Reactions: 2s2f, Klassek and XIX

DISCLAIMER:

This is not medical advice, and the only purpose this serves is a sarcastic interpretation of someone trying to help mitigate the side effects of people already on Erdafitinib.

Much safer alternatives to Erdafitinib exist e.g. Infigratinib, and no side effect can be completely mitigated.
ERDAFITINIB CAN LEAD TO BLINDNESS, KYPHOSIS, SCOLIOSIS AND SO MUCH MORE.


Erdafitinib Support Protocol

Erdafitinib works by blocking FGFR receptors 1 through 4 throughout the body. Because these receptors also regulate normal processes unrelated to cancer signaling — phosphate balance, methylation, cAMP production, retinal fluid transport — inhibiting them produces a predictable set of off-target effects. countering it early is the point of this protocol.



1. Hyperphosphatemia

FGFR signaling normally activates FGF23, a bone hormone that tells the kidneys to excrete excess phosphate. Blocking FGFR removes that signal, so phosphate climbs — quietly, with no short-term symptoms. Left unchecked over months, it binds calcium and deposits in blood vessels and organs (vascular calcification), which is largely irreversible and raises both cardiovascular risk and the rate of kidney decline.

Target: serum phosphate below 5.5 mg/dL, checked every 3–4 weeks early in treatment.

Counter — Sevelamer, 800 mg with every meal. A non-absorbed gut binder: it captures dietary phosphate before it crosses into the bloodstream and carries it out in stool, so it doesn't interact with erdafitinib itself. It only works with food — useless taken on an empty stomach. Separate it from fat-soluble vitamins by at least 2 hours, since it reduces their absorption too.

2. Methylation Burden

Methylation moves a methyl group from SAM-e to other molecules and runs constantly — detox, gene expression, neurotransmitter synthesis, drug metabolism all draw on it. Erdafitinib is partly cleared through this same pathway, so it consumes SAM-e on top of everything else. Over time, demand outpaces what diet replenishes, the cycle backs up, and homocysteine rises — itself a risk factor for cardiovascular disease, clotting, and cognitive decline, and one that compounds the cardiovascular strain from elevated phosphate. Creatine synthesis alone accounts for a large share of the body's methyl-group demand.

Counter — Methyl Support
  • Creatine monohydrate, 5 g/day — supplementing bypasses the body's own creatine synthesis (normally ~40% of daily methyl demand), freeing up SAM-e elsewhere. No loading phase needed.​
  • Betaine (TMG), 3 g/day, split into two doses — donates methyl groups directly and converts homocysteine back to methionine through a pathway that doesn't depend on B12 or folate, actively clearing the buildup.​

3. Suppressed cAMP Signaling

cAMP is an intracellular messenger that governs energy metabolism, inflammation, cell survival, and hormone response. FGFR signaling normally feeds into cAMP production, so blocking it cuts that input. The downstream effects — lower mitochondrial output, impaired fat metabolism, reduced stress tolerance, blunted immune surveillance — show up mainly as a fatigue that builds gradually and doesn't resolve with sleep.

Counter — cAMP Support
  • Abaloparatide, 80 mcg (preferred where affordable) — a PTH-related protein analogue that activates PTH1R, a receptor coupled to adenylyl cyclase (the enzyme that produces cAMP), restoring output through a pathway independent of the blocked FGFR signal.​
  • Forskolin, 1 g/day (cheaper alternative) — activates adenylyl cyclase directly, without needing a receptor, raising cAMP broadly.​

4. Ocular Effects

FGFR receptors in the retinal pigment epithelium, choroid, and cornea help regulate fluid transport. Blocking them disrupts subretinal fluid balance, which can cause central serous retinopathy (CSR) — fluid accumulating under the retina, distorting central vision and reducing contrast. It develops slowly enough that many people don't notice until it's already significant. The same blockade disrupts the tear film, causing dry eye.

Counter — Eye Protection
  • Dorzolamide eye drops, started at 2–3 months in or at the first visual symptom — a topical carbonic anhydrase inhibitor that reduces subretinal fluid production, addressing CSR directly, with minimal systemic exposure. Use preservative-free formulations.​
  • Lubricating drops as needed for dryness; switch to preservative-free if used more than 4x/day.​

5. Dehydration and Kidney Load

Erdafitinib clears through the liver, then the kidneys. Inadequate hydration raises drug-metabolite concentration with each filtration cycle, compounding the kidney stress already caused by elevated phosphate — and it further concentrates circulating phosphate, undermining the sevelamer, while also worsening dry eye and fatigue. It's the most overlooked piece of this protocol because it has no dramatic acute symptom to flag it.

Counter — Hydration Protocol
  • 3 L water/day — 500 mL first thing in the morning, the rest spread through the day rather than taken all at once, to avoid diluting sodium.​
  • Electrolytes daily — a sugar-free sodium/potassium/magnesium supplement, dissolved in at least 1 L of the daily water.​
  • Saffron extract (crocetin), 30 mg/day — supports renal microcirculation and reduces inflammatory signaling in the kidney.​


TL;DR: Protocol

ED, from day one:
  • Creatine monohydrate — 5 g​
  • Betaine (TMG) — 3 g, split morning/evening​
  • Abaloparatide 80 mcg or forskolin 1 g​
  • Saffron extract (crocetin) — 30 mg​
  • Sevelamer — 800 mg with every meal​
  • Electrolytes + 3 L water, spread through the day​

Starting at 2–3 months, or at first visual symptom:
  • Dorzolamide eye drops (preservative-free preferred)​
  • Lubricating drops (preservative-free if used more than 4x/day)​

Monitoring / Bloodwork:
  • Serum phosphate — target below 5.5 mg/dL​
  • Kidney function markers — every 4–6 weeks​
  • Vision — central clarity/contrast​
  • Homocysteine — every 8 weeks​

Every item on this list has a specific job targeting a specific side effect, so take them all.

@Volpa #volpamogs
Mirin, would love to use this but i’m not on erda
 
  • +1
Reactions: 2s2f and XIX

DISCLAIMER:

This is not medical advice, and the only purpose this serves is a sarcastic interpretation of someone trying to help mitigate the side effects of people already on Erdafitinib.

Much safer alternatives to Erdafitinib exist e.g. Infigratinib, and no side effect can be completely mitigated.
ERDAFITINIB CAN LEAD TO BLINDNESS, KYPHOSIS, SCOLIOSIS AND SO MUCH MORE.


Erdafitinib Support Protocol

Erdafitinib works by blocking FGFR receptors 1 through 4 throughout the body. Because these receptors also regulate normal processes unrelated to cancer signaling — phosphate balance, methylation, cAMP production, retinal fluid transport — inhibiting them produces a predictable set of off-target effects. countering it early is the point of this protocol.



1. Hyperphosphatemia

FGFR signaling normally activates FGF23, a bone hormone that tells the kidneys to excrete excess phosphate. Blocking FGFR removes that signal, so phosphate climbs — quietly, with no short-term symptoms. Left unchecked over months, it binds calcium and deposits in blood vessels and organs (vascular calcification), which is largely irreversible and raises both cardiovascular risk and the rate of kidney decline.

Target: serum phosphate below 5.5 mg/dL, checked every 3–4 weeks early in treatment.

Counter — Sevelamer, 800 mg with every meal. A non-absorbed gut binder: it captures dietary phosphate before it crosses into the bloodstream and carries it out in stool, so it doesn't interact with erdafitinib itself. It only works with food — useless taken on an empty stomach. Separate it from fat-soluble vitamins by at least 2 hours, since it reduces their absorption too.

2. Methylation Burden

Methylation moves a methyl group from SAM-e to other molecules and runs constantly — detox, gene expression, neurotransmitter synthesis, drug metabolism all draw on it. Erdafitinib is partly cleared through this same pathway, so it consumes SAM-e on top of everything else. Over time, demand outpaces what diet replenishes, the cycle backs up, and homocysteine rises — itself a risk factor for cardiovascular disease, clotting, and cognitive decline, and one that compounds the cardiovascular strain from elevated phosphate. Creatine synthesis alone accounts for a large share of the body's methyl-group demand.

Counter — Methyl Support
  • Creatine monohydrate, 5 g/day — supplementing bypasses the body's own creatine synthesis (normally ~40% of daily methyl demand), freeing up SAM-e elsewhere. No loading phase needed.​
  • Betaine (TMG), 3 g/day, split into two doses — donates methyl groups directly and converts homocysteine back to methionine through a pathway that doesn't depend on B12 or folate, actively clearing the buildup.​

3. Suppressed cAMP Signaling

cAMP is an intracellular messenger that governs energy metabolism, inflammation, cell survival, and hormone response. FGFR signaling normally feeds into cAMP production, so blocking it cuts that input. The downstream effects — lower mitochondrial output, impaired fat metabolism, reduced stress tolerance, blunted immune surveillance — show up mainly as a fatigue that builds gradually and doesn't resolve with sleep.

Counter — cAMP Support
  • Abaloparatide, 80 mcg (preferred where affordable) — a PTH-related protein analogue that activates PTH1R, a receptor coupled to adenylyl cyclase (the enzyme that produces cAMP), restoring output through a pathway independent of the blocked FGFR signal.​
  • Forskolin, 1 g/day (cheaper alternative) — activates adenylyl cyclase directly, without needing a receptor, raising cAMP broadly.​

4. Ocular Effects

FGFR receptors in the retinal pigment epithelium, choroid, and cornea help regulate fluid transport. Blocking them disrupts subretinal fluid balance, which can cause central serous retinopathy (CSR) — fluid accumulating under the retina, distorting central vision and reducing contrast. It develops slowly enough that many people don't notice until it's already significant. The same blockade disrupts the tear film, causing dry eye.

Counter — Eye Protection
  • Dorzolamide eye drops, started at 2–3 months in or at the first visual symptom — a topical carbonic anhydrase inhibitor that reduces subretinal fluid production, addressing CSR directly, with minimal systemic exposure. Use preservative-free formulations.​
  • Lubricating drops as needed for dryness; switch to preservative-free if used more than 4x/day.​

5. Dehydration and Kidney Load

Erdafitinib clears through the liver, then the kidneys. Inadequate hydration raises drug-metabolite concentration with each filtration cycle, compounding the kidney stress already caused by elevated phosphate — and it further concentrates circulating phosphate, undermining the sevelamer, while also worsening dry eye and fatigue. It's the most overlooked piece of this protocol because it has no dramatic acute symptom to flag it.

Counter — Hydration Protocol
  • 3 L water/day — 500 mL first thing in the morning, the rest spread through the day rather than taken all at once, to avoid diluting sodium.​
  • Electrolytes daily — a sugar-free sodium/potassium/magnesium supplement, dissolved in at least 1 L of the daily water.​
  • Saffron extract (crocetin), 30 mg/day — supports renal microcirculation and reduces inflammatory signaling in the kidney.​


TL;DR: Protocol

ED, from day one:
  • Creatine monohydrate — 5 g​
  • Betaine (TMG) — 3 g, split morning/evening​
  • Abaloparatide 80 mcg or forskolin 1 g​
  • Saffron extract (crocetin) — 30 mg​
  • Sevelamer — 800 mg with every meal​
  • Electrolytes + 3 L water, spread through the day​

Starting at 2–3 months, or at first visual symptom:
  • Dorzolamide eye drops (preservative-free preferred)​
  • Lubricating drops (preservative-free if used more than 4x/day)​

Monitoring / Bloodwork:
  • Serum phosphate — target below 5.5 mg/dL​
  • Kidney function markers — every 4–6 weeks​
  • Vision — central clarity/contrast​
  • Homocysteine — every 8 weeks​

Every item on this list has a specific job targeting a specific side effect, so take them all.

@Volpa #volpamogs
nice :transRainbow:
 

Similar threads

F
Replies
20
Views
160
thebigone
T
erome
Replies
39
Views
221
Rashm0n
Rashm0n
chigga6
Replies
1
Views
59
ilikefish
ilikefish
F
Replies
2
Views
52
ltnfoidraperer
ltnfoidraperer
B
Replies
3
Views
69
Niebvll
Niebvll

Users who are viewing this thread

  • tuktukdriver
  • Altairplanetsw
Back
Top